News

Tagworks' ceo Marc Robillard will present Tagworks' technology at the Spring symposium of the French Society for Medicinal Chemistry on 'Bioorthogonal Chemistry contributing to Molecular Therapeutic Innovation' in Paris.

The latest edition of Medicines, a Dutch journal on drug development, features Tagworks Pharmaceuticals in the start-up sections. The article by Rik Nijland appeared in Medicines 1, February 2015 (in Dutch) 24_25_med1_startup

Developing an antibody tag with improved pharmacokinetics and stability allowed Tagworks to achieve increased tumor uptake of a radiolabeled pretargeting probe. Even though this adapted tag exhibited a slight loss in reactivity, its use in a antibody (CC49-TCO) conjugate demonstrated a longer clearance half-life, improved tumor accumulation and increased in …

Approaches that use in vivo chemistry to enable non-invasive molecular imaging and therapy are much sought after. Taking the recent achievements in pretargeted radioimmuno-imaging and -therapy in mice as a starting point, the Tagworks team discuss how the application scope of this approach can eventually be extended towards humans. Read …

Tagworks will participate in NanoCity 2014, October 27-28 in Utrecht, The Netherlands. More on the event: www.nanocity2014.com  

Tagworks will participate in the US National Cancer Institute's IMAT (Innovative Molecular Analysis Technologies) Principal Investigator's meeting on 12-13 November 2014 in Bethesda.

Tagworks has been invited to participate in the World ADC Mastermind session on 26 August 2014 in Cambridge, UK  

World ADC, 23-25 February 2015, Frankfurt, Germany More on the conference: adcsummit-europe.com

World ADC, 26-29 October 2014, San Diego More on the conference: adc-summit.com

World Molecular Imaging Congress, 17-20 September 2014, Seoul, Korea More on the conference: www.wmis.org